Eli Lilly Market Cap

Eli Lilly has a market cap or net worth of $782.07 billion as of April 28, 2026. Its market cap has increased by 12.62% in one year.

Market Cap

782.07B

Enterprise Value

818.45B

1-Year Change

12.62%

Ranking

#15

Market Cap Chart

Since December 1, 1998, Eli Lilly's market cap has increased from $99.25B to $782.07B, an increase of 688.00%. That is a compound annual growth rate of 7.82%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	824.49B	-18.85%
Dec 31, 2025	1,015.99B	38.63%
Dec 31, 2024	732.87B	32.44%
Dec 29, 2023	553.37B	59.19%
Dec 30, 2022	347.61B	31.56%
Dec 31, 2021	264.23B	63.60%
Dec 31, 2020	161.51B	27.99%
Dec 31, 2019	126.19B	2.94%
Dec 31, 2018	122.58B	31.81%
Dec 29, 2017	93.00B	14.54%
Dec 30, 2016	81.20B	-13.04%
Dec 31, 2015	93.37B	21.55%
Dec 31, 2014	76.82B	33.69%
Dec 31, 2013	57.46B	0.39%
Dec 31, 2012	57.23B	18.95%
Dec 30, 2011	48.12B	19.08%
Dec 31, 2010	40.41B	-1.52%
Dec 31, 2009	41.03B	-10.38%
Dec 31, 2008	45.79B	-24.40%
Dec 31, 2007	60.56B	2.72%
Dec 29, 2006	58.96B	-8.34%
Dec 30, 2005	64.32B	0.16%
Dec 31, 2004	64.22B	-18.68%
Dec 31, 2003	78.97B	10.71%
Dec 31, 2002	71.33B	-19.21%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Johnson & Johnson	542.44B
AbbVie	349.12B
AstraZeneca	293.62B
Novartis AG	277.41B
Merck & Co.	272.25B
Amgen	183.59B
Novo Nordisk	183.47B
Gilead Sciences	158.57B

Market Cap Rankings